this is simply too cool: not directly... - Fight Prostate Ca...

Fight Prostate Cancer

2,802 members1,032 posts

this is simply too cool: not directly related to PCa but worth a read

Maxone73 profile image
5 Replies

New molecular device unlocks potential for targeted drug delivery and self-healing materials

”The researchers from The University of Manchester describe a force-controlled release system that harnesses natural forces to trigger targeted release of molecules, which could significantly advance medical treatment and smart materials.”

phys.org/news/2024-04-molec...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
5 Replies
j-o-h-n profile image
j-o-h-n

targeted drug delivery (ready, fire, aim)

Good Luck, Good Health and Good Humor.

j-o-h-n

Maxone73 profile image
Maxone73 in reply to j-o-h-n

like I did while I was in the air force!

j-o-h-n profile image
j-o-h-n in reply to Maxone73

Which one? Our side or the Other side?

Good Luck, Good Health and Good Humor.

j-o-h-n

Maxone73 profile image
Maxone73 in reply to j-o-h-n

Our side...whatever it means!

j-o-h-n profile image
j-o-h-n

Good, cause the other side learns the words "I surrender" in 28 different languages....

Good Luck, Good Health and Good Humor.

j-o-h-n

You may also like...

New strategies against bone metastases from prostate cancer - Science Daily

pathway targets in bone metastases,\\" Owens says. \\"This is significant because we could...

Coronavirus (COVID-19) Supply Chain Update - FDA Statement - February 27, 2020

those on prescription drugs, it might be good to monitor the FDA press releases and also to top-off...

[i][b]How Prostate Cancer May Begin - ScienceDaily, September 21, 2022[/b][/i]

21, 2022, University of East Anglia....

Finally Undetectable PSA on BAT

to my oligometastatic nodes followed by molecular targeting radioligand treatments using the...

Efficacy and safety of BAT in CRPC following Abi or Enza resistance: A systematic review

that can restore some patients' sensitivity to drugs such as abiraterone (Abi) and enzalutamide...